Ashley Cimino‐Mathews

8.1k total citations
122 papers, 3.8k citations indexed

About

Ashley Cimino‐Mathews is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Ashley Cimino‐Mathews has authored 122 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Oncology, 44 papers in Cancer Research and 33 papers in Pathology and Forensic Medicine. Recurrent topics in Ashley Cimino‐Mathews's work include Breast Cancer Treatment Studies (26 papers), Breast Lesions and Carcinomas (24 papers) and Cancer Immunotherapy and Biomarkers (22 papers). Ashley Cimino‐Mathews is often cited by papers focused on Breast Cancer Treatment Studies (26 papers), Breast Lesions and Carcinomas (24 papers) and Cancer Immunotherapy and Biomarkers (22 papers). Ashley Cimino‐Mathews collaborates with scholars based in United States, Belgium and Germany. Ashley Cimino‐Mathews's co-authors include Pedram Argani, Rajni Sharma, Leisha A. Emens, Janis M. Taube, Peter B. Illei, Alan K. Meeker, Elizabeth D. Thompson, Ben Ho Park, Andrea P. Subhawong and Russell Vang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Ashley Cimino‐Mathews

113 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashley Cimino‐Mathews United States	37	2.2k	924	922	907	784	122	3.8k
Asma Tulbah Saudi Arabia	31	1.9k 0.9×	880 1.0×	837 0.9×	533 0.6×	765 1.0×	104	3.3k
Roland Penzel Germany	40	1.8k 0.8×	1.7k 1.8×	1.3k 1.4×	1.5k 1.6×	257 0.3×	134	4.4k
Rohit Bhargava United States	41	2.8k 1.3×	1.6k 1.7×	2.4k 2.6×	1.2k 1.3×	303 0.4×	171	5.5k
Snjezana Doğan United States	31	2.0k 0.9×	1.2k 1.3×	565 0.6×	1.4k 1.5×	327 0.4×	89	4.6k
Stephen Lade Australia	20	909 0.4×	1.1k 1.2×	689 0.7×	280 0.3×	543 0.7×	46	3.2k
Thierry Lesimple France	32	2.0k 0.9×	1.2k 1.3×	401 0.4×	1.0k 1.1×	416 0.5×	139	3.3k
Yun Gong United States	35	1.9k 0.9×	1.1k 1.2×	1.1k 1.2×	1.0k 1.1×	205 0.3×	118	3.6k
Yan‐Gao Man United States	28	1.2k 0.5×	1.3k 1.4×	1.1k 1.2×	382 0.4×	495 0.6×	95	3.1k
Josep M. Piulats Spain	30	1.5k 0.7×	1.1k 1.2×	448 0.5×	847 0.9×	894 1.1×	162	3.2k
Takayuki Kinoshita Japan	34	1.9k 0.9×	900 1.0×	2.1k 2.3×	737 0.8×	238 0.3×	174	4.2k

Countries citing papers authored by Ashley Cimino‐Mathews

Since Specialization

Citations

This map shows the geographic impact of Ashley Cimino‐Mathews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Cimino‐Mathews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Cimino‐Mathews more than expected).

Fields of papers citing papers by Ashley Cimino‐Mathews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Cimino‐Mathews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Cimino‐Mathews. The network helps show where Ashley Cimino‐Mathews may publish in the future.

Co-authorship network of co-authors of Ashley Cimino‐Mathews

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Cimino‐Mathews. A scholar is included among the top collaborators of Ashley Cimino‐Mathews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Cimino‐Mathews. Ashley Cimino‐Mathews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mi, Haoyang, Ravi Varadhan, Ashley Cimino‐Mathews, et al.. (2024). Spatial Architecture of Single-Cell and Vasculature in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer. Modern Pathology. 38(2). 100652–100652. 6 indexed citations

Deutsch, Julie S., Tricia R. Cottrell, Krista Y. Chen, et al.. (2024). Pan-tumor harmonization of pathologic response assessment for standardized data collection in neoadjuvant IO trials (PATHdata): Final analysis of a multi-institutional reproducibility study.. Journal of Clinical Oncology. 42(16_suppl). 2515–2515.

White, Marissa J. & Ashley Cimino‐Mathews. (2024). Diagnostic Approach to Mesenchymal and Spindle Cell Tumors of the Breast. Advances in Anatomic Pathology. 31(6). 411–428.

Huang, Tzu‐Ting, Jayakumar R. Nair, Daniel An, et al.. (2023). BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer. Science Translational Medicine. 15(701). eadd7872–eadd7872. 17 indexed citations

Banet, Natalie, Maryam Shahi, Denise Batista, et al.. (2021). HER-2 Amplification in Uterine Serous Carcinoma and Serous Endometrial Intraepithelial Carcinoma. The American Journal of Surgical Pathology. 45(5). 708–715. 23 indexed citations

Myers, Kelly S., Eniola Oluyemi, Mehran Habibi, et al.. (2021). Pre-Operative Localization of Axillary Lymph Nodes with Tattoo Ink: A Preliminary Report. SHILAP Revista de lepidopterología. 143–148. 1 indexed citations

Nunes, Raquel, Tal Sella, Kai Treuner, et al.. (2021). Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma. Clinical Cancer Research. 27(20). 5688–5696. 13 indexed citations

Ščupáková, Klára, Benjamin Balluff, Vinay Ayyappan, et al.. (2021). Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis. JCI Insight. 6(24). 62 indexed citations

Cimino‐Mathews, Ashley, Yoni Lubeck, Mark Opdam, et al.. (2020). Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy. European Journal of Cancer. 127. 240–250. 18 indexed citations

10.

Lampert, Erika J., Alexandra S. Zimmer, Michelle R. Padget, et al.. (2020). Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study. Clinical Cancer Research. 26(16). 4268–4279. 150 indexed citations

11.

Stein, Julie E., Evan J. Lipson, Tricia R. Cottrell, et al.. (2019). Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade. Clinical Cancer Research. 26(3). 545–551. 92 indexed citations

12.

Hornick, Jason L., Rhonda K. Yantiss, Laura W. Lamps, et al.. (2018). USCAP 2018 Abstracts: Genitourinary Pathology (894–1126). Modern Pathology. 31(S2). 323a–403. 3 indexed citations

13.

Beierl, Katie, Christopher D. Gocke, Daniel J. Zabransky, et al.. (2017). Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component. Clinical Cancer Research. 23(16). 4875–4884. 29 indexed citations

14.

Robertson, Scott, Ashley Cimino‐Mathews, & Toby C. Cornish. (2016). HER2 Status in Gastroesophageal Adenocarcinomas: Correlation Between Immunohistochemistry and Fluorescence In Situ Hybridization Methodologies. Applied immunohistochemistry & molecular morphology. 26(1). 35–39. 1 indexed citations

15.

Thompson, Elizabeth D., Janis M. Taube, Hillary Elwood, et al.. (2016). The immune microenvironment of breast ductal carcinoma in situ. Modern Pathology. 29(3). 249–258. 116 indexed citations

16.

Cowan, Morgan L., Pedram Argani, & Ashley Cimino‐Mathews. (2016). Benign and low-grade fibroepithelial neoplasms of the breast have low recurrence rate after positive surgical margins. Modern Pathology. 29(3). 259–265. 47 indexed citations

17.

D’Alfonso, Timothy M., et al.. (2013). SP3, a reliable alternative to HercepTest in determining HER-2/neu status in breast cancer patients. Journal of Clinical Pathology. 66(5). 409–414. 4 indexed citations

18.

Cimino‐Mathews, Ashley, Andrea P. Subhawong, Peter B. Illei, et al.. (2013). GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas. Human Pathology. 44(7). 1341–1349. 157 indexed citations

19.

Shah, Nilay, Kideok Jin, Sunju Park, et al.. (2013). HOXB13 Mediates Tamoxifen Resistance and Invasiveness in Human Breast Cancer by Suppressing ERα and Inducing IL-6 Expression. Cancer Research. 73(17). 5449–5458. 76 indexed citations

20.

Cimino‐Mathews, Ashley, Andrea P. Subhawong, Hillary Elwood, et al.. (2012). Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas. Human Pathology. 44(6). 959–965. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact